Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.
Show more...
CEO
Richard Chin
직원
63
국가
US
상장
0 Comments
생각을 공유하기
FAQ
오늘 Kindred Biosciences 주가는 얼마인가요?▼
KIN의 현재 가격은 $9.25 USD이며, 지난 24시간 동안 +0.11% 상승했습니다. 차트에서 Kindred Biosciences 주가 흐름을 더 자세히 살펴보세요.
Kindred Biosciences의 주식 심볼은 무엇인가요?▼
거래소에 따라 주식 심볼이 다를 수 있습니다. 예를 들어, 거래소에서는 Kindred Biosciences 주식이 KIN 심볼로 거래됩니다.